[纳米白蛋白结合型紫杉醇联合铂类化疗作为一名非小细胞肺癌患者的六线治疗方案]
[Nab-Paclitaxel with platinum chemotherapy as sixth-line therapy for a non-small cell lung cancer patient].
作者信息
Ishiura Yoshihisa, Shiba Yasutaka, Terasaki Yasushi, Hinoue Yoshinobu, Ishida Youichi, Segawa Masataka, Saitoh Katsuhiko, Hirokami Norikazu, Kasahara Kazuo, Fujimura Masaki
机构信息
Dept. of Medical Oncology, Toyama City Hospital.
出版信息
Gan To Kagaku Ryoho. 2015 Apr;42(4):493-5.
A 48-year-old woman was admitted to our hospital for sixth-line chemotherapy. A chest X-ray film and computed tomographic (CT) scan revealed a right-sided massive tumor with multiple lung tumors. Repeated treatment with carboplatin (AUC 6) on day 1 and nab-paclitaxel (100mg/m2) on days 1, 8, and 15, every 28 days were effective in this patient. Chemotherapy with nab-paclitaxel may be effective for patients with multi-recurrent adenocarcinoma.
一名48岁女性因接受第六线化疗入院。胸部X光片和计算机断层扫描（CT）显示右侧有一个巨大肿瘤以及多个肺部肿瘤。该患者每28天重复进行一次化疗，第1天使用卡铂（AUC 6），第1、8和15天使用纳米白蛋白结合型紫杉醇（100mg/m²），治疗有效。纳米白蛋白结合型紫杉醇化疗可能对多次复发的腺癌患者有效。
Zotero 插件